Tissue cholesterol content alterations in streptozotocin-induced diabetic rats

Acta Pharmacologica Sinica

Volumn 33, Issue 7, 2012, Pages 909-917

  Wang, Xin Ting ^a   Li, Jia ^a   Liu, Li ^a   Hu, Nan ^a   Jin, Shi ^a   Liu, Can ^a   Mei, Dan ^a   Liu, Xiao Dong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

ABCA1; apolipoprotein E; cholesterol; diabetes; liver X receptor

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL; MESSENGER RNA; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE; KIDNEY; LIVER; MALE; NONHUMAN; PANCREAS; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TISSUE LEVEL; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; INSULIN; MALE; ORPHAN NUCLEAR RECEPTORS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 84863678571     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2012.50     Document Type: Article

References (53)

1. Wadwa RP, Kinney GL, Maahs DM, Snell-Bergeon J, Hokanson JE, Garg SK, et al. Awareness and treatment of dyslipidemia in young adults with type 1 diabetes. Diabetes Care 2005; 28: 1051-6.
2. Miyazaki A, Sakashita N, Lee O, Takahashi K, Horiuchi S, Hakamata H, et al. Expression of ACAT-1 protein in human atherosclerotic lesions and cultured human monocytes-macrophages. Arterioscler Thromb Vasc Biol 1998; 18: 1568-74.
3. Paulson KE, Zhu S-N, Chen M, Nurmohamed S, Jongstra-Bilen J, Cybulsky MI. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ Res 2010; 106: 383-90.
4. Jun JY, Ma Z, Segar L. Spontaneously diabetic Ins2+/Akita: apoEdeficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis. Am J Physiol Endocrinol Metab 2011; 301: E145-54.
5. James SH, Meyers AM. Microangiopathic hemolytic anemia as a complication of diabetes mellitus. Am J Med Sci 1998; 315: 211-5.
6. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008; 70: 1972-9.
7. Hartmann T. Cholesterol, A and Alzheimer's disease. Trends Neurosci 2001; 24: S45-8.
8. Luo DX, Cao DL, Xiong Y, Peng XH, Liao DF. A novel model of cholesterol efflux from lipid-loaded cells. Acta Pharmacol Sin 2010; 31: 1243-57.
9. Calkin AC, Forbes JM, Smith CM, Lassila M, Cooper ME, Jandeleit-Dahm KA, et al. Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects. Arterioscler Thromb Vasc Biol 2005; 25: 1903-9.
10. Tang C, Kanter JE, Bornfeldt KE, Leboeuf RC, Oram JF. Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 2010; 51: 1719-28.
11. Dong J, Chen W, Wang S, Zhang J, Li H, Guo H, et al. Jones oxidation and high performance liquid chromatographic analysis of cholesterol in biological samples. J Chromatogr B 2007; 858: 239-46.
12. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357-66.
13. Honda A, Yamashita K, Hara T, Ikegami T, Miyazaki T, Shirai M, et al. Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. J Lipid Res 2009; 50: 350-7.
14. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2'CT method. Methods 2001; 25: 402-8.
15. Liu H, Xu X, Yang Z, Deng Y, Liu X, Xie L. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocininduced diabetic rats. Brain Res 2006; 1123: 245-52.
16. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMPinducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000; 275: 34508-11.
17. Li D, Wang D, Wang Y, Ling W, Feng X, Xia M. Adenosine monophosphate activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in Apolipoprotein E-deficient mice. J Biol Chem 2010; 285: 33499-509.
18. Rahman SMA, Van Dam AM, Schultzberg M, Crisby M. High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. J Neuroimmunol 2005; 169: 59-67.
19. Vance JE, Hayashi H. Formation and function of apolipoprotein E-containing lipoproteins in the nervous system. Biochim Biophys Acta 2010; 1801: 806-18.
20. Hayashi H. Lipid metabolism and glial lipoproteins in the central nervous system. Biol Pharm Bull 2011; 34: 453-61.
21. Lane RM, Farlow MR. Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease. J Lipid Res 2005; 46: 949-68.
22. Wilson JD. The measurement of the exchangeable pools of cholesterol in the baboon. J Clin Invest 1970; 49: 655-65.
23. Dell RB, Mott GE, Jackson EM, Ramakrishnan R, Carey KD, McGill HC, et al. Whole body and tissue cholesterol turnover in the baboon. J Lipid Res 1985; 26: 327-37.
24. Prince PSM, Kannan NK. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocininduced diabetic rats. J Pharm Pharmacol 2006; 58: 1373-83.
25. Geethan PK, Prince PS. Antihyperlipidemic effect of D-pinitol on streptozotocin-induced diabetic wistar rats. J Biochem Mol Toxicol 2008; 22: 220-4.
26. Sarkar C, Cenedella R. Reactivity of key metabolic sterols in standard colorimetric assays for cholesterol. Lipids 1982; 17: 46-9.
27. Morris TG. A comparison of methods for the estimation of serum cholesterol and values in random samples of populations in the 55-64 age group. J Clin Path 1959; 12: 518-23.
28. Uehara Y, Engel T, Li Z, Goepfert C, Rust S, Zhou X, et al. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002; 51: 2922-8.
29. Shen L, Tso P, Woods SC, Clegg DJ, Barber KL, Carey K, et al. Brain Apolipoprotein E: an important regulator of food intake in rats. Diabetes 2008; 57: 2092-8.
30. Lenich CM, Chobanian AV, Brecher P, Zannis VI. Effect of dietary cholesterol and alloxan-diabetes on tissue cholesterol and apolipoprotein E mRNA levels in the rabbit. J Lipid Res 1991; 32: 431-8.
31. Suzuki R, Lee K, Jing E, Biddinger SB, McDonald JG, Montine TJ, et al. Diabetes and insulin in regulation of brain cholesterol metabolism. Cell Metab 2010; 12: 567-79.
32. Russell DW, Halford RW, Ramirez DMO, Shah R, Kotti T. Cholesterol 24-hydroxylase: An enzyme of cholesterol turnover in the brain. Annu Rev Biochem 2009; 78: 1017-40.
33. Kamboj SS, Chopra K, Sandhir R. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation. Neuroscience 2009; 162: 349-58.
34. Nonomura K, Arai Y, Mitani H, Abe-Dohmae S, Yokoyama S. Insulin down-regulates specific activity of ATP-binding cassette transporter A1 for high density lipoprotein biogenesis through its specific phosphorylation. Atherosclerosis 2011; 216: 334-41.
35. Gerin I, Dolinsky VW, Shackman JG, Kennedy RT, Chiang S-H, Burant CF, et al. LXR is required for adipocyte growth, glucose homeostasis, and cell function. J Biol Chem 2005; 280: 23024-31.
36. Huang TH-W, Razmovski-Naumovski V, Salam NK, Duke RK, Tran VH, Duke CC, et al. A novel LXR-activator identified from the natural product Gynostemma pentaphyllum. Biochem Pharmacol 2005; 70: 1298-308.
37. Tamehiro N, Sato Y, Suzuki T, Hashimoto T, Asakawa Y, Yokoyama S, et al. Riccardin C: A natural product that functions as a liver X receptor (LXR) agonist and an LXR antagonist. FEBS Lett 2005; 579: 5299-304.
38. Shimano H, Yahagi N, Amemiya-Kudo M, Hasty AH, Osuga J, Tamura Y, et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem 1999; 274: 35832-9.
39. Eberlé D, Hegarty B, Bossard P, Ferré P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie 2004; 86: 839-48.
40. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL. Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 1999; 96: 13656-61.
41. Schiefelbein D, Goren I, Fisslthaler B, Schmidt H, Geisslinger G, Pfeilschifter J, et al. Biphasic regulation of HMG-CoA reductase expression and activity during wound healing and its functional role in the control of keratinocyte angiogenic and proliferative responses. J Biol Chem 2008; 283: 15479-90.
42. Easom RA, Zammit VA. Effects of diabetes on the expressed and total activities of 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver in vivo. Reversal by insulin treatment. Biochem J 1985; 230: 747-52.
43. Ravid Z, Bendayan M, Delvin E, Sane AT, Elchebly M, Lafond J, et al. Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors. Am J Physiol Gastrointest Liver Physiol 2008; 295: G873-85.
44. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006; 55: 2502-9.
45. Zhao C, Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J Endocrinol 2010; 204: 233-40.
46. Zager RA. Plasma membrane cholesterol: A critical determinant of cellular energetics and tubular resistance to attack. Kidney Int 2000; 58: 193-205.
47. Wang H, Xie X, Zhang F, Zhou Q, Tao Q, Zou Y, et al. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel -cyclodextrin derivatives. Food Chem Toxicol 2011; 49: 1387-93.
48. Tsujikawa H, Song Y, Watanabe M, Masumiya H, Gupte SA, Ochi R, et al. Cholesterol depletion modulates basal L-type Ca2+ current and abolishes its -adrenergic enhancement in ventricular myocytes. Am J Physiol Heart Circ Physiol 2008; 294: H285-92.
49. Sones WR, Davis AJ, Leblanc N, Greenwood IA. Cholesterol depletion alters amplitude and pharmacology of vascular calcium-activated chloride channels. Cardiovasc Res 2010; 87: 476-84.
50. Balut C, Steels P, Radu M, Ameloot M, Driessche WV, Jans D. Membrane cholesterol extraction decreases Na+ transport in A6 renal epithelia. Am J Physiol Cell Physiol 2006; 290: C87-94.
51. Hao M, Head WS, Gunawardana SC, Hasty AH, Piston DW. Direct effect of cholesterol on insulin secretion. Diabetes 2007; 56: 2328-38.
52. Larsson S, Wierup N, Sundler F, Eliasson L, Holm C. Lack of cholesterol mobilization in islets of hormone-sensitive lipase deficient mice impairs insulin secretion. Biochem Biophys Res Commun 2008; 376: 558-62.
53. Hao M, Bogan JS. Cholesterol regulates glucose-stimulated insulin secretion through phosphatidylinositol 4,5-bisphosphate. J Biol Chem 2009; 284: 29489-98.